Perception Neuroscience
atai Life Sciences
R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
J Zhang, S Li, K Hashimoto - Pharmacology Biochemistry and Behavior, 2014 - Elsevier
Comparative pharmacology of the ketamine isomers: studies in volunteers
PF White, J Schüttler, A Shafer… - BJA: British Journal …, 1985 - academic.oup.com
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C Yang, Y Shirayama, JC Zhang, Q Ren, W Yao… - Translational …, 2015 - nature.com
Intravenous arketamine for treatment-resistant depression: Open-label pilot study
GC Leal, ID Bandeira, FS Correia-Melo… - European Archives of …, 2020 - Springer
Depression as a neuroendocrine disorder: Emerging neuropsychopharmacological approaches beyond monoamines
M Chávez-Castillo, V Nuñez, M Nava… - Advances in …, 2019 - hindawi.com
Impact of age on optimal dose of antidepressants
K Hashimoto - EClinicalMedicine, 2020 - ncbi.nlm.nih.gov
Method of treating pain and depression using a hybrid mixture of s-ketamine and r-ketamine
G Jay - US Patent App. 15/849,587, 2018 - Google Patents
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority …
FS Correia-Melo, GC Leal, F Vieira… - Journal of Affective …, 2020 - Elsevier
Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review
RI Memon, S Naveed, AE Faquih, A Fida, N Abbas… - Psychiatric …, 2020 - Springer
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography …
FX Vollenweider, KL Leenders, I Øye, D Hell… - European …, 1997 - Elsevier
Metabolism of ketamine stereoisomers by human liver microsomes
ED Kharasch, R Labroo - … : The Journal of …, 1992 - anesthesiology.pubs.asahq.org
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
J Schüttler, DR Stanski, PF White, AJ Trevor, Y Horai… - 1987 - Springer
Lack of dopamine D 1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model
L Chang, K Zhang, Y Pu, Y Qu, S Wang, Z Xiong… - European Archives of …, 2020 - Springer
Glutamate Modulators in Major Depressive Disorder
TM Cooper, DV Iosifescu - Major Depressive Disorder, 2020 - Elsevier
Psychedelics
DE Nichols - Pharmacological reviews, 2016 - ASPET
Psychedelics encyclopedia
P Stafford - 2013 - books.google.com
Psychedelics and the human receptorome
TS Ray - PloS one, 2010 - journals.plos.org
Psychedelics and the essential importance of context
RL Carhart-Harris, L Roseman… - Journal of …, 2018 - journals.sagepub.com
Psychedelics and mental health: a population study
TS Krebs, PØ Johansen - PloS one, 2013 - journals.plos.org
Psychedelics as medicines: an emerging new paradigm
DE Nichols, MW Johnson… - Clinical Pharmacology & …, 2017 - Wiley Online Library
Psychedelics: Where we are now, why we got here, what we must do
SJ Belouin, JE Henningfield - Neuropharmacology, 2018 - Elsevier
Psychedelics promote structural and functional neural plasticity
C Ly, AC Greb, LP Cameron, JM Wong, EV Barragan… - Cell reports, 2018 - Elsevier
REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics
RL Carhart-Harris, KJ Friston - Pharmacological reviews, 2019 - ASPET
How do psychedelics work?
RL Carhart-Harris - Current opinion in psychiatry, 2019 - journals.lww.com
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2021 - nature.com